Oncaspar (Pegaspargase) 750 U/ml
Known name: Pegaspargase
Oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukemia (ALL) in pediatric patients and adult patients from birth to 18 years of age.
Pegaspargase, which is sold under the brand name Oncaspar, is a drug used in treatment of acute lymphoblastic leukemia. It is often used in combination with anthracycline, vincristine, and prednisone. It is used with injection.
Oncaspar (Pegaspargase) 750 U/ml You can contact us to find out the price:Contact for detailed information